Skip to Content

Acticor Biotech SA - Stock Quote ALACT

Rating as of

Morningstar's Acticor Biotech SA Stock Analysis

Valuation
Currency in EUR
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price

PREMIUM

5-Star Price

PREMIUM

Economic Moat

PREMIUM

About Quantitative Ratings

Morningstar Quantitative ratings for equities (denoted on this page by) are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies withratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating. Click here for more on how to use these ratings.

Acticor Biotech SA's Company Profile

Business Description

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Contact
46 rue Henri Huchard, Hopital Bichat - INSERM U1148
Paris, 75877, France
Sector Healthcare
Industry Biotechnology
Most Recent Earnings
Fiscal Year End
Stock Type
Employees 25